Scientists Win Nobel Medicine Prize for Optogenetics

Nobel Prize Recognises Breakthrough in Brain Research

American scientist Karl Deisseroth and German scientists Peter Hegemann and Georg Nagel have won the 2026 Nobel Prize in Physiology or Medicine for their pioneering work on optogenetics. The technique allows researchers to control individual nerve cells using light.

How Optogenetics Works

Optogenetics combines genetics and light to control the activity of specific neurons. The breakthrough began with research on light-sensitive proteins found in algae. Hegemann and Nagel identified channelrhodopsin, a light-sensitive ion channel, while Deisseroth later demonstrated how the technique could control nerve cells in the brain.

According to The Hindu BusinessLine, the discovery has transformed neuroscience by allowing scientists to study how specific brain circuits influence behaviour, emotions and memory. The technology has also helped researchers investigate conditions such as depression, addiction, Parkinson’s disease and Alzheimer’s disease.

Potential Medical Applications

Researchers are now exploring whether optogenetics could help develop treatments for neurological and psychiatric disorders. Scientists are also studying its potential to restore vision in people with certain forms of blindness.

Also Read |  Inflammageing and Longevity: A Joint Initiative by Illness to Wellness Foundation and Celiac Society of India

The Nobel recognition highlights how a discovery rooted in basic research has opened new possibilities for understanding the human brain and developing future medical treatments.